These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9628610)

  • 1. Serum levels of total and free prostate specific antigen in men on hemodialysis.
    Sasagawa I; Kubota Y; Hayami S; Adachi M; Nakada T; Miura H; Imai K
    J Urol; 1998 Jul; 160(1):83-5. PubMed ID: 9628610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of prostate specific antigen in men on hemodialysis.
    Wolff JM; Ting O; Borchers H; Rohde D; Jakse G
    Anticancer Res; 2000; 20(6D):5191-3. PubMed ID: 11326693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer screening with prostate-specific antigen in hemodialysis patients.
    Horinaga M; Kitamura K; Saito S; Ukimura O; Nakanoma T; Okihara K; Kitagawa M; Nakanishi H; Miki T
    Urol Int; 2007; 78(4):334-7. PubMed ID: 17495492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hemodialysis on serum complexed prostate-specific antigen levels.
    Tarhan F; Orçun A; Küçükercan I; Camursoy N; Kuyumcuoglu U
    Scand J Urol Nephrol; 2007; 41(5):382-6. PubMed ID: 17853041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
    Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
    Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of prostate-specific antigen and vitamin D in peritoneal dialysis patients.
    Passadakis P; Ersoy F; Tam P; Memmos D; Siamopoulos K; Ozener C; Akçiçek F; Camsari T; Ates K; Ataman R; Vlachojannis J; Dombros N; Utas C; Akpolat T; Bozfakioglu S; Wu GG; Karayaylali I; Arinsoy T; Stathakis C; Yavuz M; Tsakiris D; Dimitriades A; Yilmaz ME; Gültekin M; Karayalçin B; Challa A; Polat N; Oreopoulos DG
    Adv Perit Dial; 2004; 20():203-8. PubMed ID: 15384827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ratios of free to total prostate-specific antigen and total prostate specific antigen to protein concentrations in saliva and serum of healthy men.
    Ayatollahi H; Darabi Mahboub MR; Mohammadian N; Parizadeh MR; Kianoosh T; Khabbaz Khoob M; Kamalian F
    Urol J; 2007; 4(4):238-41. PubMed ID: 18270950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary/serum prostate-specific antigen ratio: comparison with free/total serum prostate-specific antigen ratio in improving prostate cancer detection.
    Irani J; Salomon L; Soulié M; Zlotta A; de la Taille A; Doré B; Millet C
    Urology; 2005 Mar; 65(3):533-7. PubMed ID: 15780371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do changes in a high serum prostate-specific antigen level and the free/total prostate-specific antigen ratio after antibiotic treatment rule out biopsy and the suspicion of cancer?
    Dirim A; Tekin MI; Koyluoglu E; Oguzulgen AI; Peskircioglu L; Ozkardes H
    Urol Int; 2009; 82(3):266-9. PubMed ID: 19440011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels.
    Ramos CG; Carvahal GF; Mager DE; Haberer B; Catalona WJ
    J Urol; 1999 Nov; 162(5):1587-90. PubMed ID: 10524873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
    Culp S; Porter M
    BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
    Haese A; Dworschack RT; Partin AW
    J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological variation of total, free and percent free serum prostate specific antigen levels in screening volunteers.
    Ornstein DK; Smith DS; Rao GS; Basler JW; Ratliff TL; Catalona WJ
    J Urol; 1997 Jun; 157(6):2179-82. PubMed ID: 9146610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of renal transplantation on serum-free and total PSA levels.
    Kamali K; Zargar MA
    Transplant Proc; 2007 May; 39(4):1027-8. PubMed ID: 17524882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical usefulness of free PSA/total PSA ratio in the early diagnosis of prostatic cancer].
    Laguna Pes MP; Guinda Sevillano C; Zazo Romojaro A; Domínguez J; García Luzón A; Borrego Hernando J; Gimeno Collado A
    Arch Esp Urol; 2000 May; 53(4):333-41. PubMed ID: 10900763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass screening for prostate cancer in patients with end-stage renal disease: a comparative study.
    Wada Y; Nakanishi J; Takahashi W; Kai N; Nakayama Y; Yamashita Y; Honda J; Ueda S
    BJU Int; 2006 Oct; 98(4):794-7. PubMed ID: 16978274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer.
    Brawer MK; Cheli CD; Neaman IE; Goldblatt J; Smith C; Schwartz MK; Bruzek DJ; Morris DL; Sokoll LJ; Chan DW; Yeung KK; Partin AW; Allard WJ
    J Urol; 2000 May; 163(5):1476-80. PubMed ID: 10751861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay standardization bias: different prostate cancer detection rates and clinical outcomes resulting from different assays for free and total prostate-specific antigen.
    Sotelo RJ; Mora KE; Pérez LH; Novoa J; Carmona O; De Andrade R; Borges RE; Parada D; Loeb S; Catalona WJ
    Urology; 2007 Jun; 69(6):1143-6. PubMed ID: 17572203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical usefulness of serum antip53 antibodies for prostate cancer detection: a comparative study with prostate specific antigen parameters.
    Suzuki H; Akakura K; Igarashi T; Ueda T; Ito H; Watanabe M; Nomura F; Ochiai T; Shimada H
    J Urol; 2004 Jan; 171(1):182-6. PubMed ID: 14665872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive criteria for prostate cancer detection in men with serum PSA concentration of 2.0 to 4.0 ng/mL.
    Kravchick S; Peled R; Dorfman D; Agulansky L; Ben-Dor D; Cytron S
    Urology; 2005 Sep; 66(3):542-6. PubMed ID: 16140074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.